But much of what gets reported as lean mass loss has not been proven to be skeletal muscle loss
Furthermore, from 2010-2023 the FDA has received 265 reports of suicidal thoughts in patients taking GLP-1 receptor agonists, particularly tirzepatide, liraglutide, and semaglutide, prompting a review of these medications [34,35]
We encourage our clients to pair their aesthetic treatments with supportive lifestyle habits including adequate protein intake, consistent hydration, and regular movement to maximize and sustain their results
[5] When the body experiences sudden weight reduction, it can interpret this as physiological stress, prompting hair follicles to shift prematurely into the resting phase
Phase 2 - Staying the Course (month 3 and beyond) Dose: 0.5 to 1.5 mg weekly
Telogen effluvium from rapid metabolic shifts The most common cause of GLP-1 related hair loss is telogen effluvium, a condition where a large percentage of hair follicles simultaneously shift from the anagen (growth) phase to the telogen (resting) phase